At Chu Vision Institute, Dr. Jessica Heckman says eyesight does indeed change when people are in their 40s. "It's called ...

Developments include low-dose atropine eye drops and LASIK procedures. The global myopia and presbyopia treatment market is ...

DelveInsight's“Presbyopia Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Presbyopia, historical and forecasted epidemiology as well as the ...

The FDA has approved the first and so far only pharmacological treatment for presbyopia, a sight condition that typically starts in middle age and involves difficulty in focusing on near objects ...

Presbyopia is caused by a stiffening in the lens of the eye that develops in people after the age of 40, and affects an estimated 128 million people in the US. AbbVie is recommending Vuity ...

008). Topline data were announced from a phase 3 trial evaluating Brimochol TM preservative-free (PF), an investigational pupil-modulating therapeutic, in adults with presbyopia. Study ...

The merger brings together a late-stage, potentially best-in-class, presbyopia-correcting eye drop, BRIMOCHOL™ PF, on track for NDA filing in 1H, 2025, with a promising pipeline of innovative ...